FDA accepts vilazodone NDA

FDA accepted an NDA from Clinical Data Inc. (NASDAQ:CLDA) for vilazodone to treat major depressive disorder (MDD). The acceptance triggered a EUR 12.5 million ($15.6 million) milestone payment to Merc...